Navigation Links
Breast Cancer Patients Often Confused by Genomic Testing
Date:3/8/2010

Doctors should do more to explain test results, researchers find

MONDAY, March 8 (HealthDay News) -- Doctors need to do a better job of explaining genomic test results to breast cancer patients, say U.S. researchers.

Genomic testing -- which analyzes 21 genes in breast tumors removed during surgery in order to predict the risk of cancer recurrence -- can help guide decisions about the use of chemotherapy in patients with early-stage breast cancer. Patients at high risk may decide on more aggressive treatment, while those at low risk may opt to forego chemotherapy and its potential side effects.

For this study, researchers surveyed 77 patients with early-stage, estrogen receptor-positive breast cancer who underwent genomic testing between 2004 and 2009.

About one-third of the women said they felt they did not fully understand their discussions with doctors about their genomic test results and their risk of cancer recurrence, and about one-quarter suffered distress.

"Almost all women agreed that having the test gave them a better understanding of their treatment options chance of success," Noel Brewer, an assistant professor of health behavior and health education at the University of North Carolina's Gillings School of Public Health, said in a news release. "Most women said that they would have the test if they had to decide again today, and that they would recommend the test to other women in their same situation."

The researchers also found that most women accurately remembered the risk results from their genomic test.

While most patients in the study had a positive attitude about genomic testing and felt that it helped them better understand their treatment options, there is room for improvement in how doctors discuss cancer recurrence risk and treatment decisions with patients, Brewer and colleagues concluded.

The study is published online March 8 in the journal Cancer.

More information

The American Association for Clinical Chemistry has more about breast cancer testing.



-- Robert Preidt



SOURCE: Cancer, news release, March 8, 2010


'/>"/>
Copyright©2010 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Survival differences by race most apparent in advanced stages of breast cancer
2. MRI finds breast cancer before it becomes dangerous
3. Pathway links inflammation, angiogenesis and breast cancer
4. Drop in breast cancer incidence linked to hormone use, not mammograms
5. Breast cancer prevention practices vary across Canada
6. Eating junk food whilst pregnant and breastfeeding may lead to obese offspring
7. Acrylamide Wont Raise Breast Cancer Risk
8. New link between estrogen and breast cancer
9. Hypnosis Eases Pain of Breast Cancer Surgery
10. Discovery suggests location of genes for breast density, a strong risk factor for breast cancer
11. Longaberger Expands Horizon of Hope Campaign to Build Support for American Cancer Societys Breast Cancer Initiatives
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell ... pain and the benefits of holistic treatments, Serenity Recovery Center of Marne, ... Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
(Date:6/24/2016)... NY (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin ... companies that call for a minimum wage raise to $12 an hour by 2020 and ... This will restore the lost value of the minimum wage, assure the wage floor does ...
(Date:6/24/2016)... Georgia (PRWEB) , ... June 24, 2016 , ... ... awards today at the Clinical Decision Making in Emergency Medicine conference in Ponte ... have authored journal articles published in Emergency Medicine Practice and Pediatric ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) announced ... Act of 1976, as amended ("HSR"), with respect to ... CPXX ) expired effective June 24, 2016, ... previously announced on May 31, 2016, Jazz Pharmaceuticals and ... Jazz Pharmaceuticals has commenced a tender offer for all ...
(Date:6/24/2016)... SAN FRANCISCO, Calif. , June 24, 2016 ... GBT ), a biopharmaceutical company developing novel therapeutics ... significant unmet needs, today announced the closing of ... shares of common stock, at the public offering ... shares in the offering were offered by GBT. ...
(Date:6/24/2016)... BEIJING , June 24, 2016 Dehaier ... or the "Company"), which develops, markets and sells medical ... China , signed a strategic cooperation agreement with ... as "Hongyuan Supply Chain") on June 20, 2016, to ... Under the strategic cooperation agreement, Dehaier will leverage Hongyuan ...
Breaking Medicine Technology: